Downloads: 0 | Views: 72
Research Paper | Pharmacy | India | Volume 12 Issue 8, August 2023
ADR Monitoring and Reporting in General Medicine Department of Tertiary Care Hospital
Dr. Zeenath Unnissa | Ainul Husna | Syeda Fathma Husna | Tania Farooqui | Farha Naseer | Majida Begum
Abstract: Background: Anadverse drug reaction (ADR) is defined as a response to a medicinal product that is noxious and unintended. ADRs drive up healthcare expenses and significantly contribute to morbidity and mortality. Pharmacovigilance systems help regulatory agency choices made in many nations by detecting signals from data from the worldwide ADR register and preventing risks associated with drug usage, particularly for recently commercialized pharmaceuticals. Only a few medications are taken off the market, primarily because of hepatotoxicity. The biggest drawback of automatic notification of ADRs is under - reporting, which makes it the least expensive, most accessible, and most popular way to identify new drug safety issues. Increased patient, physician, government, and pharmaceutical company involvement and the application of new technology will characterize the future of pharmacovigilance and ADRs. Methods: A prospective observational study conducted in a tertiary care hospital over a period of 3 months. All patients meeting inclusion criterea were enrolled in study. Results and Discussion: Out of 50 patients 17 adr were collected and majority adr were occured in age group 31 - 45 years, according to Causality assessment 17 adrs were probable of which 8 adrs were mild and contributed to 47.8% of total ADR. Most of the patients who experienced ADR, were recovered with the treatment and management of ADR including drug withdrawal. A total of 5 drug related ADR were observed during study which were considered already as drug alerts by pharmacovigilance drug safety alert. Conclusion: Patients? safety and improvement in health care delivery system is important and one crucial step is reporting adr. By reporting adr and providing important drug information, patients quality of life can be improved.
Keywords: Adverse drug reaction, Pharmacovigilance, Drug alerts, Patients safety
Edition: Volume 12 Issue 8, August 2023,
Pages: 282 - 288